NEW YORK, Nov. 9 /PRNewswire-FirstCall/ -- Lev Pharmaceuticals, Inc. (OTC Bulletin Board: LEVP.OB) today announced that it will conduct a conference call and audio web cast on Tuesday, November 13, 2007, at 1:00 p.m. Eastern Time (ET), in conjunction with the release of its financial results for the third quarter ended September 30, 2007. Lev anticipates releasing its financial results at 7:00 a.m. ET on Tuesday, November 13, 2007.
DATE: November 13, 2007
TIME: 1PM ET
DIAL IN #: (800) 320-2978
INT'L #: (617) 614-4923
To access the live webcast, please click on the following link: http://phx.corporate-ir.net/playerlink.zhtml?c=130944&s=wm&e=1692330.
A replay of this webcast will be available for 30 days.
The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents at: http://www.streetevents.com, a password-protected event management site.
About Lev Pharmaceuticals, Inc.
Lev is a biopharmaceutical company focused on developing and
commercializing therapeutic products for the treatment of inflammatory
diseases. Lev's C1 inhibitor, to be marketed as Cinryze(TM), has been
granted orphan drug status for the treatment and prevention of HAE,
potentially securing, upon approval, market exclusivity for seven years.
Lev has also received fast track designation status from the FDA, which
facilitates the development and expedites the review of drugs and biologics
intended to treat serious or life threatening conditions and tha
|SOURCE Lev Pharmaceuticals, Inc.|
Copyright©2007 PR Newswire.
All rights reserved